Jaleel Ayesha, Saag Kenneth G, Danila Maria I
Brookwood Baptist Health, Birmingham, AL, USA.
University of Alabama at Birmingham, Birmingham, AL, USA.
Ther Adv Musculoskelet Dis. 2018 Jul;10(7):141-149. doi: 10.1177/1759720X18785539. Epub 2018 Jul 10.
Similar to other chronic diseases such as diabetes and hypertension, osteoporosis has struggled with suboptimal medication adherence, resulting in an increased risk of fractures and all-cause mortality. The goal of this narrative review was to summarize interventions to improve medication adherence in osteoporosis. Because past reviews of this topic covered published literature through 2013, we conducted our literature search to include the period between January 2012 and November 2017. We identified 10 studies evaluating healthcare system and patient interventions aimed at improving osteoporosis treatment adherence, including three fracture liaison service (FLS) programs, one pharmacist-delivered counseling program, and six patient-directed interventions consisting of three coaching or counseling programs and three interventions using reminder prompts. Four out of the six patient-directed interventions did not lead to significant improvements in outcomes, suggesting that patient-directed interventions may have limited success in this setting. The healthcare system interventions that evaluated FLS programs and pharmacist-directed tailored counseling were effective at improving medication adherence; however, the studies were not randomized, they were costly, resource intensive and effective in countries with more centralized healthcare, possibly limiting their generalizability. In conclusion, while healthcare system interventions such as FLS, and pharmacist-delivered counseling appeared to be successful in improving osteoporosis medication adherence in some settings, behavioral interventions including patient counseling and reminder prompts for medication utilization were not, perhaps due to patient perceptions regarding osteoporosis consequences and need for treatment. Thus, these patient attributes may define patients 'at high risk' for poor adherence and developing intervention approaches to enhance patient knowledge and understanding of osteoporosis and its consequences may improve the perception of the need for treatment, optimize osteoporosis care and thereby improve overall outcomes of patients with osteoporosis. We hope that the knowledge gained through our review will help inform the design of further programs aimed at optimizing osteoporosis care.
与糖尿病和高血压等其他慢性疾病类似,骨质疏松症一直存在药物依从性欠佳的问题,导致骨折风险和全因死亡率增加。本叙述性综述的目的是总结改善骨质疏松症药物依从性的干预措施。由于以往关于该主题的综述涵盖了截至2013年的已发表文献,我们进行了文献检索,纳入了2012年1月至2017年11月期间的研究。我们确定了10项评估旨在改善骨质疏松症治疗依从性的医疗系统和患者干预措施的研究,包括3个骨折联络服务(FLS)项目、1个药剂师提供的咨询项目,以及6个患者导向干预措施,其中包括3个指导或咨询项目和3个使用提醒提示的干预措施。6个患者导向干预措施中有4个未导致结果有显著改善,这表明在这种情况下患者导向干预措施可能成效有限。评估FLS项目和药剂师指导的个性化咨询的医疗系统干预措施在改善药物依从性方面是有效的;然而,这些研究并非随机对照研究,成本高昂、资源密集,且在医疗保健更为集中的国家有效,这可能限制了它们的可推广性。总之,虽然诸如FLS等医疗系统干预措施以及药剂师提供的咨询在某些情况下似乎成功改善了骨质疏松症药物依从性,但包括患者咨询和药物使用提醒提示在内的行为干预措施却未成功,这可能是由于患者对骨质疏松症后果和治疗需求的认知所致。因此,这些患者特征可能界定了依从性差的“高风险”患者,制定干预方法以增强患者对骨质疏松症及其后果的认识和理解,可能会改善对治疗需求的认知,优化骨质疏松症护理,从而改善骨质疏松症患者的总体结局。我们希望通过本综述获得的知识将有助于为旨在优化骨质疏松症护理的进一步项目设计提供参考。